TAMPA, Fla.--(BUSINESS WIRE)--Clinical data utilizing the DRX9000 True Non-Surgical Spinal Decompression System™ will be presented at the PainWeek Conference in Las Vegas, September 4-6, 2008. The first, is an IRB-approved, prospective multi-center phase II, non-randomized pilot study authored by Dr. John Leslie of the Mayo Clinic and others. This study was designed to evaluate the effectiveness and safety of the DRX9000 in treating chronic lower back pain. A greater than 50% reduction in pain score was observed after two weeks of treatment, and upon completion of the entire six week protocol an amazing success rate of 88.9% was documented. Improvement of Oswestry scores and a decreased consumption of adjunctive pain medication was also noted. The second, is retrospective data which included lumbar spine CT scans before and after patients were treated on the DRX9000 that demonstrates possible morphological changes associated with treatment. Dr. Christian Apfel, MD, Associate Professor of Anesthesiology and Perioperative Care at the University of California at San Francisco, will present this data at the PainWeek Conference. Dr. Apfel, lead author and his colleagues conclude, “A significant reduction in chronic LBP [lower back pain] after non-invasive spinal decompression correlated with an increase in disc height.” Abstracts of both studies will be available during the 2008 PainWeek Conference.
